Antimicrobial stewardship program-led carbapenem restriction: a cost-effectiveness analysis

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: YOU, Joyce (The Chinese University of Hong Kong, School of Pharmacy, Shatin, Hong Kong SAR China)
  • Co-author(s): Sheung-Yin Choi School of Pharmacy, The Chinese University of Hong Kong, Shatin, Hong Kong
    Joyce You
  • Abstract:

    Background

    Carbapenem is typically reserved for treatment of multidrug-resistant pathogens, yet its usage has been increasing globally. Carbapenem misuse can lead to carbapenem-resistant Enterobacteriaceae. Antimicrobial stewardship program (ASP) aims to improve clinical outcomes and reduce antibiotic-associated Clostridium difficile infection..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login